📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Sofregen

1.1 - Company Overview

Sofregen Logo

Sofregen

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of silk-based medical implants and injectable biomaterials, including the Silk Voice Injectable Implant for vocal fold medialization and insufficiency, and injectable silk protein microparticle-based fillers for soft tissue augmentation and collagen production; previously offered the SERI Surgical Scaffold (discontinued as of Dec 31, 2021).

Products and services

  • Silk Voice Injectable Implant: An injectable, silk-and-hyaluronic-acid implant engineered for vocal fold medialization, designed to address vocal fold insufficiency
  • Injectable Silk Protein Microparticle-based Fillers: Engineered, silk protein microparticles formulated as injectable fillers to enable soft tissue augmentation and stimulate collagen production
  • SERI Surgical Scaffold: An implantable, silk-based biological scaffold constructed for tissue support and regeneration, no longer commercially available as of December 31, 2021

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Sofregen

Tepha Logo

Tepha

HQ: United States Website
  • Description: Provider of a new class of absorbable biomaterials for medical devices, developing and commercializing proprietary polyhydroxyalkanoate technology tailored to meet unmet needs across multiple fields and to be used in surgical procedures.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Tepha company profile →
Cutiss Logo

Cutiss

HQ: Switzerland Website
  • Description: Provider of regenerative medicine and skin tissue engineering solutions, including denovoSkin, a personalized bio-engineered skin graft for permanent treatment of skin defects and injuries; Viticell, a CE-marked cell therapy for vitiligo and dyspigmented burn scars; automated manufacturing of tissue therapies, clinical development programs, and named-patient basis treatment options.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Cutiss company profile →
ACell Logo

ACell

HQ: United States Website
  • Description: Provider of extracellular matrix devices and acellular, resorbable MatriStem/UBM matrices for tissue repair and remodeling in surgical and wound care, including Cytal Wound Matrix, Cytal Burn Matrix, MicroMatrix UBM Particulate, and Gentrix Surgical Matrix.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ACell company profile →
Lotus Tissue Repair Logo

Lotus Tissue Repair

HQ: United States Website
  • Description: Provider of proprietary recombinant human collagen Type VII (rC7) technology for accelerating chronic wound healing in dermatologic conditions, including diabetic foot ulcers, venous stasis ulcers and similar conditions.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lotus Tissue Repair company profile →
Harbor MedTech Logo

Harbor MedTech

HQ: United States Website
  • Description: Provider of tissue regeneration products for chronic wounds, hernia and joint repair. Offers Architect, a stabilized collagen matrix for various chronic skin wounds; BPMatrix, a collagen patch for orthopedic soft tissue injuries such as tendon repairs; and BriDGE Technology, a patented method to create a stabilized collagen matrix that supports tissue regeneration, accelerates wound healing, and prevents infection.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Harbor MedTech company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Sofregen

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Sofregen

2.2 - Growth funds investing in similar companies to Sofregen

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Sofregen

4.2 - Public trading comparable groups for Sofregen

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Sofregen

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Sofregen

What does Sofregen do?

Sofregen is a provider of silk-based medical implants and injectable biomaterials, including the Silk Voice Injectable Implant for vocal fold medialization and insufficiency, and injectable silk protein microparticle-based fillers for soft tissue augmentation and collagen production; previously offered the SERI Surgical Scaffold (discontinued as of Dec 31, 2021).

Who are Sofregen's competitors?

Sofregen's competitors and similar companies include Tepha, Cutiss, ACell, Lotus Tissue Repair, and Harbor MedTech.

Where is Sofregen headquartered?

Sofregen is headquartered in United States.

How many employees does Sofregen have?

Sofregen has 1,000 employees 🔒.

When was Sofregen founded?

Sofregen was founded in 2010 🔒.

What sector and industry vertical is Sofregen in?

Sofregen is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Sofregen

Who are the top strategic acquirers in Sofregen's sector and industry

Top strategic M&A buyers and acquirers in Sofregen's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Sofregen?

Top strategic M&A buyers groups and sectors for Sofregen include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Sofregen's sector and industry vertical

Which are the top PE firms investing in Sofregen's sector and industry vertical?

Top PE firms investing in Sofregen's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Sofregen's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Sofregen's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Sofregen's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Sofregen include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Sofregen's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Sofregen?

The key public trading comparables and valuation benchmarks for Sofregen include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Sofregen for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Sofregen with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Sofregen's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Sofregen with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Sofregen's' sector and industry vertical?

Access recent funding rounds and capital raises in Sofregen's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Sofregen